Publicaciones y presentaciones
Descubra los principales aspectos destacados de nuestra industria en nuestras publicaciones más recientes.
Acceso Rápido
Presentaciones
Publicaciones
Key Economic & Value Considerations in the US
Market for PPTs
Market for PPTs
Key Economic & Value Considerations for PDMPs
in Europe
in Europe
Plasma donation: New thinking to serve Europe’s patients -- Practices & approaches for countries
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jan 20, 2011
Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
Virus removal by partitioning into different fractions during cold ethanol fractionation has been described by several authors, demonstrating that cold ethanol fractionation can provide significant contribution to virus removal, even in those cases where virus removal is limited and must be supported by additional measures for virus inactivation during further processing.
All
Publication
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1537-2995.2010.03003.x
Jan 20, 2011
Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
Virus removal by partitioning into different fractions during cold ethanol fractionation has been described by several authors, demonstrating that cold ethanol fractionation can provide significant contribution to virus removal, even in those cases where virus removal is limited and must be supported by additional measures for virus inactivation during further processing.
All
Publication
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1537-2995.2010.03003.x
Plasma Collections and Immunoglobulin Manufacturing in the Era of COVID-19
Normal human immunoglobulins (IG) are used to treat patients with primary and secondary antibody deficiencies to supplement missing or malfunctioning antibodies and prevent occurrence of severe infections.
All
Publication
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6452a91991968119deb1c3d7_Cervenakova%20L_ESID_2020_e-Poster.pdf
Plasma Collections and Immunoglobulin Manufacturing in the Era of COVID-19
Normal human immunoglobulins (IG) are used to treat patients with primary and secondary antibody deficiencies to supplement missing or malfunctioning antibodies and prevent occurrence of severe infections.
All
Publication
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6452a91991968119deb1c3d7_Cervenakova%20L_ESID_2020_e-Poster.pdf
No results found